The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: Population-based, data-linkage study

Thorax

Volumn 70, Issue 2, 2015, Pages 138-145

  Forrest, Lynne F ^a,b   Adams, Jean ^a,b   Rubin, Greg ^a,c   White, Martin ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; SOCIAL DISCRIMINATION; SURVIVAL RATE; SURVIVAL TIME; TIME TO TREATMENT; TREATMENT PLANNING; TREND STUDY; CARCINOMA, NON-SMALL-CELL LUNG; ECONOMICS; ENGLAND; EPIDEMIOLOGY; GENERAL PRACTICE; HEALTH CARE DISPARITY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATIENT REFERRAL; SMALL CELL LUNG CARCINOMA; SOCIAL CLASS; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; ENGLAND; FEMALE; GENERAL PRACTICE; HEALTHCARE DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; SMALL CELL LUNG CARCINOMA; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TIME FACTORS; TIME-TO-TREATMENT;

EID: 84921307965     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205517     Document Type: Article

References (33)

1. White M, Adams J, Heywood P. How and why do interventions that increase health overall widen inequalities within populations? In: Babones S, ed. Health, inequality and society. Bristol: Policy Press, 2009:65-83.
2. Forrest LF. Why are socioeconomic inequalities in receipt of treatment found for lung cancer? Lung Cancer Management 2013;2:177-80.
3. Cancer Research UK. Cancer incidence: UK statistics (18/12/13). http://info.cancerresearchuk.org/cancerstats/incidence/
4. Howlader NNA, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) National Cancer Institute. Bethesda, MD 2011, based on November 2011 SEER data submission, posted to SEER web site 2. http://seer.cancer.gov/csr/1975-2009-pops09/
5. Cancer Research UK. Common cancers - UK mortality statistics (18/12/13). http://info.cancerresearchuk.org/cancerstats/mortality/cancerdeaths/
6. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
7. Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 2010;103:446-53.
8. Coleman MP, Babb P, Sloggett A, et al. Socio-economic inequalities in cancer survival in England and Wales. Cancer 2001;91:208-16.
9. Forrest LF, Adams J, Wareham H, et al. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med 2013;10:e1001376.
10. Forrest LF, White M, Rubin G, et al. The role of patient, tumour and system factors on socioeconomic inequalities in lung cancer treatment: population-based study. Br J Cancer 2014. doi:10.1038/bjc.2014.310
11. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006;17:5-19.
12. Richards MA. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009;101(S2):S1-4.
13. NYCRIS. Northern and Yorkshire Cancer Registry and Information Centre, 2012. (cited 2013 02/08/2013). http://www.nycris.nhs.uk/about/
14. Ludbrook JJS, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol 2003;55:1321-30.
15. NHS Information Centre. National Lung Cancer Audit Report 2012. Leeds: NHS Information Centre for Health and Social Care, 2012.
16. HM Government. English Indices of Deprivation 2010. 2013.
17. Department of Health. The NHS cancer plan: a plan for investment, a plan for reform. 2000.
18. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
19. Cancer Research UK. More about staging for lung cancer (27/01/14). http://www.cancerresearchuk.org/cancer-help/type/lung-cancer/treatment/more-about-lung-cancer-staging
20. NICE. Clinical Guideline 24. Lung Cancer: the diagnosis and treatment of lung cancer. London: NICE, 2005.
21. Kirkwood BR, Sterne JA. Regression modelling. In: Essential Medical Statistics. 2nd edn. Oxford: Blackwell Publishing Ltd, 2003:315-42.
22. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32:1135-41.
23. Sorensen J, Klee M, Palshof T, et al. Performance status in cancer patients. An inter-observer variability study. Br J Cancer 1993;67:773-5.
24. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stats Med 2011;30:377-99.
25. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
26. Crawford SM, Sauerzapf V, Haynes R, et al. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009;101:897-901.
27. Jack RH, Gulliford MC, Ferguson J, et al. Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract 2006;12:573-82.
28. Louwman WJ, Aarts MJ, Houterman S, et al. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 2010;103:1742-8.
29. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-41.
30. National Patient Safety Agency. Delayed diagnosis of cancer: Thematic review. London: National Reporting and Learning Service, 2010.
31. Jensen AR, Mainz J, Overgaard J. Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncol 2002;41:147-52.
32. Olsson JK, Schultz EM, Gould MK. Timeliness of care in patients with lung cancer: a systematic review. Thorax 2009;64:749-56.
33. Torring ML, Frydenberg M, Hansen RP, et al. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer 2011;104:934-40.